Non-resorbing osteoclasts induce migration and osteogenic differentiation of mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 109, Issue 2, 2010, Pages 347-355

  Kreja, L ^a   Brenner, R E ^a   Tautzenberger, A ^a   Liedert, A ^a   Friemert, B ^b   Ehrnthaller, C ^a   Huber Lang, M ^a   Ignatius, A ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Military Hospital   (Germany)

Author keywords

BMP 2; Bone remodeling; Chemotaxis; Mesenchymal stem cell; Osteoclast; Osteogenic differentiation; PDGF BB

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BONE SIALOPROTEIN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; MARKER GENE; MESENCHYMAL STEM CELL; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION;

ALKALINE PHOSPHATASE; BONE MARROW CELLS; BONE RESORPTION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOTAXIS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CULTURE MEDIA, CONDITIONED; HUMANS; MESENCHYMAL STEM CELLS; MONOCYTES; OSTEOCLASTS; OSTEOGENESIS; OSTEOPONTIN; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIALOGLYCOPROTEINS;

EID: 74949138882     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22406     Document Type: Article

References (42)

1. Andersen TL, Sondergaard TE, Skorzynska KE, Dagnaes-Hansen F, Plesner TL, Hauge EM, Plesner T, Delaisse J-M. 2009. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 174:239-247.
2. Asagiri M, Takayanagi H. 2007. The molecular understanding of osteoclast differentiation. Bone 40:251-264.
3. Bar-Shavit Z. 2007. The osteoclast: A multinucleated, hemopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 102:1130-1139.
4. Boyce BF, Xing L. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Biochem Biophys Res Commun 473:139-146.
5. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
6. Buckley KA, Chan BYY, Fraser WD, Gallagher JA. 2005. Human osteoclast culture from peripheral blood monocytes: Phenotypic characterization and quantitation of resorption. Methods Mol Med 107:55-68.
7. Fickert S, Fiedler J, Brenner RE. 2004. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther 6:R422-R432.
8. Fiedler J, Roderer G, Gunther KP, Brenner RE. 2002. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87:305-313.
9. Fiedler J, Etzel N, Brenner RE. 2004. To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990-998.
10. Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE. 2005. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334:561-568.
11. Fiedler J, Brill C, Blum W, Brenner RE. 2006. IGF-I and IGF-II stimulate cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun 345:1177-1183.
12. Goff L, Boucher S, Fenstermacher S, Swerdel M, Chase LG, Adams CC, Chesnut J, Lakshmipathy U, Hart R. 2008. Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: Prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol 36:1354-1369.
13. Gruber R, Karreth F, Kandler B. 2004. Platelet-released supernatants increase migration and proliferation and decreased osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 15:29-35.
14. Heng BC, Cao T, Stanton LW, Robson P, Olsen B. 2004. Strategies for differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res 19:1379-1394.
15. Huges FJ, Turner W, Belibasakis G, Martuscelli G. 2006. Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 2000 (41): 48-72.
16. Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K. 2007. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22:487-494.
17. Karsdal MA, Neutzsky-Wulff AV, Dziegiel MH, Christiansen C, Henriksen K. 2008. Osteoclasts secrete non-bone derived signals that induce bone formation. Biochem Biophys Res Commun 366:483-488.
18. Katagiri T, Takahashi N. 2002. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8:147-159.
19. Kratchmarova I, Blogoev B, Sorensen MG, Kassem M, Mann M. 2005. Mechanism of divergent growth factors in mesenchymal stem cell differentiation. Science 308:1472-1477.
20. Kreja L, Liedert A, Schmidt C, Claes L, Ignatius A. 2007. Influence of receptor activator of nuclear factor (NF)-κB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity. J Mol Histol 38:341-345.
21. Lee YM, Park YJ, Lee SJ. 2000. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. J Periodontol 71:418-424.
22. Liedert A, Kaspar D, Claes L, Ignatius A. 2006. Signal transduction pathways involved in mechanical regulation of HB-GAM expression in osteoblastic cells. Biochem Biophys Res Commun 342:1070-1076.
23. Martin TJ, Sims NA. 2005. Osteoblast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11:75-80.
24. Matsuo K, Irie N. 2008. Osteoclast-osteoblast communication. Arch Biochem Biophys 473:201-209.
25. Molchanova EA, Payushina OV, Starostin VI. 2008. Effects of growth factors on multipotent bone marrow mesenchymal stromal cells. Biol Bull 6:555-570.
26. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ. 1994. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15:203-208.
27. Neth P, Ciccarella M, Egea V, Hoelters J, Jochum M, Ries C. 2006. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 24:1892-1903.
28. Ng F, Boucher S, Koh S, Sastry KSR, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V. 2008. PDGF, TGF-β and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSC into adipogenic, chondrogenic, and osteogenic lineages. Blood 15:295-306.
29. Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M, Nikawa H, Hamada T, Kato Y. 2007. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 16:119-129.
30. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
31. Pittenger MF, Mbalaviele G, Black M, Mosca JD, Marshak DR. 2001. Mesenchymal stem cells. In: Koller MR, Palsson BO, Masters JRW, editors. Human cell culture. Dordrecht: Kluwer Academic Publisher. pp 189-207.
32. Ringe J, Strassburg S, Neumann K. 2007. Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2, and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem 101:135-146.
33. Sanches-Fernandez MA, Gallois A, Riedl T, Jurdic P, Hoflack B. 2008. Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling. PLoS ONE 3:e3537.
34. Schmidt A, Ladage D, Schinkothe T. 2006. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24:1750-1758.
35. Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, Christiansen C, Bollerslev J, Karsdai MA, Henriksen K. 2009. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet 124:561-567.
36. Son BR, Marquez-Curtis LA, Kucia M. 2006. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264.
37. Susa M, Luong-Nguyen N-H, Cappellen D, Zamurovic N, Gamse R. 2004. Human primary osteoclasts: In vitro generation and applications as pharmacological and clinical assay. J Transl Med 2:6-17.
38. Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. 2006. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24:686-695.
39. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289:1504-1508.
40. Tribault MM, Hoemann CD, Buschmann MD. 2007. Fibronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev 16:489-502.
41. Vikjaer D, Blom S, Hjorting-Hansen E. 1997. Effects of platelet-derived growth factor-BB on bone formation in calvaria defects: An experimental study in rabbits. Eur J Oral Sci 105:59-66.
42. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K. 2006. Bidirectional ephrinVB2-EphB4 signaling controls bone homeostasis. Cell Metab 4:111-121.